STOCKSCREENR

JNJ vs PFE

Comparing Johnson & Johnson (JNJ) and Pfizer Inc. (PFE) across valuation, profitability, financial health, growth, performance, and analyst metrics. Both companies operate in the Healthcare sector.

Price & Valuation

JNJ
Metric
PFE
$244.13
Price
$26.92
$588.33B
Market Cap
$153.07B
22.11
P/E Ratio
19.79
7.16
P/B Ratio
1.78
6.15
P/S Ratio
2.46
3.39
PEG Ratio
-0.93
0.00
EV/EBITDA
-152.15

Profitability

JNJ
Metric
PFE
$11.04
EPS
$1.36
+0.34%
ROE (TTM)
+0.09%
+0.13%
ROA (TTM)
+0.04%
+0.73%
Gross Margin
+0.70%
+0.27%
Operating Margin
+0.25%
+0.21%
Net Margin
-0.09%

Financial Health

JNJ
Metric
PFE
0.59
Debt/Equity
0.78
1.03
Current Ratio
1.16
0.33
Beta
0.41

Dividends

JNJ
Metric
PFE
Dividend Yield
+0.62%
Payout Ratio
-1.48%

Growth

JNJ
Metric
PFE
+0.48%
EPS Growth (YoY)
-5.08%
+0.08%
Revenue Growth (YoY)
-0.01%

Performance

JNJ
Metric
PFE
-0.12%
1 Day
+2.07%
+16.62%
1 Month
+8.36%
+14.95%
YTD
+9.65%
1 Year

Analyst

JNJ
Metric
PFE
1.00
Analyst Score
3.00
$229.33
Target Consensus
$27.60

This side-by-side comparison of Johnson & Johnson (JNJ) and Pfizer Inc. (PFE) covers key financial metrics including valuation ratios, profitability margins, balance sheet strength, dividend yields, growth rates, price performance, and analyst consensus. Green-highlighted values indicate the "winner" for each metric — higher is better for profitability and growth metrics, while lower is better for valuation and risk metrics. Use the free stock screener to compare any stocks across dozens of fundamental and technical filters.